Knight, Louise A.a; Conroy, Marka; Fernando, Augustaa; Polak, Martaa; Kurbacher, Christian M.b; Cree, Ian A.a
aTranslational Oncology Research Centre, Department of Histopathology, Queen Alexandra Hospital, Portsmouth, UK
bDivision of Clinical and Experimental Gynecologic Oncology, Department of Gynecology and Obstetrics, University of Cologne Medical Center, Cologne, Germany
Sponsorship: Zometa is a trademark of Novartis. This study was partly funded by Novartis Pharmaceuticals UK Ltd and CanTech Ltd. L. A. K. held a studentship funded by Schering Plough Ltd.
Correspondence to L. A. Knight, Translational Oncology Research Centre, Department of Histopathology, Queen Alexandra Hospital, Portsmouth PO6 3LY, UK
Tel: +44 2392 286000 ext 5355; fax: +44 2392 286379;
e-mail: [email protected]
Received 5 April 2005 Revised form accepted 23 June 2005